Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Sakkaraiappan Ramalingam"'
Autor:
Ronald G. Stoller, William C. Zamboni, David M. Friedland, Sakkaraiappan Ramalingam, Robert P. Edwards, S. Strychor, Lauren J. Maruca, Ramesh K. Ramanathan, Beth A. Zamboni, Chandra P. Belani, Huali Wu
Publikováno v:
Clinical Pharmacology & Therapeutics. 86:519-526
S-CKD602 is a pegylated liposomal formulation of CKD-602. This study is the first to evaluate the factors affecting the high interpatient variability in the pharmacokinetic disposition of S-CKD602. S-CKD602 was administered intravenously (i.v.) every
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a63282381c3996798885ce1b4ae3a7a
https://doi.org/10.1038/clpt.2009.141
https://doi.org/10.1038/clpt.2009.141
Publikováno v:
Annals of Oncology. 16:780-785
Background: Gefitinib (Iressa®) is active as a single agent in the treatment of select patients with recurrent non-small cell lung cancer (NSCLC). The clinical characteristics of patients treated with gefitinib on an Expanded Access Program (EAP) at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a78d0b932bd1d26be376b863c623caf8
https://doi.org/10.1093/annonc/mdi157
https://doi.org/10.1093/annonc/mdi157
Publikováno v:
Clinical Lung Cancer. 6:79-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109f5ecf3cca8d627d14a6046f50d97c
https://doi.org/10.1016/s1525-7304(11)70205-4
https://doi.org/10.1016/s1525-7304(11)70205-4
Autor:
Ramesh K. Ramanathan, Sakkaraiappan Ramalingam, Theodore F. Lagattuta, Merrill J. Egorin, Michael Hayes
Publikováno v:
Pharmacotherapy. 24:1232-1235
Imatinib mesylate, licensed to treat chronic myelogenous leukemia and gastrointestinal stromal tumors, is metabolized by cytochrome P450 3A and undergoes little renal excretion, but its biliary excretion by humans is uncharacterized. Liquid chromatog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2002a91efc9743482a7ebd28e1d03a01
https://doi.org/10.1592/phco.24.13.1232.38095
https://doi.org/10.1592/phco.24.13.1232.38095
Autor:
Avi I. Einzig, Chandra P. Belani, T. Dobbs, Slawomir Wojtowicz-Praga, P. Bonomi, Sakkaraiappan Ramalingam, Marianne Cascino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 53:439-444
To evaluate the efficacy of carboplatin and docetaxel combination in patients with advanced non-small-cell lung cancer. In a phase II study, patients with inoperable stage IIIB or stage IV non-small-cell lung cancer (ECOG performance status of 0 or 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae213a48edd910943e810c03e6e62801
https://doi.org/10.1007/s00280-003-0752-3
https://doi.org/10.1007/s00280-003-0752-3
Autor:
Roger Day, James R. Jett, Sakkaraiappan Ramalingam, Beth A. Zamboni, Samuel A. Jacobs, Chandra P. Belani
Publikováno v:
Annals of Oncology. 15:247-251
This phase II study was conducted to evaluate the safety and efficacy of the combination of paclitaxel and topotecan for patients with extensive stage small-cell lung cancer (ED-SCLC).Previously untreated ED-SCLC patients with Eastern Coperative Onco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78941d6efd46bcf504a21556be4d1e8d
https://doi.org/10.1093/annonc/mdh061
https://doi.org/10.1093/annonc/mdh061
Publikováno v:
Hematology/Oncology Clinics of North America. 18:13-28
Lung cancer represents a major global health problem, with more than a million deaths reported each year. Because there are no effective screening tools to date, diagnosis of the disease at an advanced stage is a common feature. Over the past 20 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de756daaaa07bae992ad1869aa48dad
https://doi.org/10.1016/s0889-8588(03)00136-9
https://doi.org/10.1016/s0889-8588(03)00136-9
Autor:
Angelia D. Gibson, Vinay K. Jain, Preeta Tyagia, Sakkaraiappan Ramalingam, Kavita Maung, Chandra P. Belani, Rafael Rosell, David J. Lee
Publikováno v:
Clinical Lung Cancer. 5:203-208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a0354fe21ac34103109c75d0b68956a
https://doi.org/10.1016/s1525-7304(11)70339-4
https://doi.org/10.1016/s1525-7304(11)70339-4
Autor:
Jennifer Klem, Kavita Maung, David Lee, Preeta Tyagi, Chandra P. Belani, Sakkaraiappan Ramalingam
Publikováno v:
Clinical Lung Cancer. 5:142-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3795aff14f557116d4ee49338082067
https://doi.org/10.1016/s1525-7304(11)70331-x
https://doi.org/10.1016/s1525-7304(11)70331-x
Autor:
Sakkaraiappan Ramalingam, Chandra P. Belani, Preeta Tyagi, Jennifer Klem, Kavita Maung, David Lee
Publikováno v:
Clinical Lung Cancer. 5:78-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60de43e111336d921db51524e8e8c95b
https://doi.org/10.1016/s1525-7304(11)70323-0
https://doi.org/10.1016/s1525-7304(11)70323-0